Fierce Pharma Asia—Eisai's subQ Leqembi delay; Legend and J&J's supply deal with Novartis; China's Ozempic biosimilar
Fierce Pharma Asia—Eisai's subQ Leqembi delay; Legend and J&J's supply deal with Novartis; China's Ozempic biosimilar
aliu
СМИ24.net — правдивые новости, непрерывно 24/7 на русском языке с ежеминутным обновлением *
